Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
₹73.25 - ₹198.86
Next Earnings Date
May 16 2025 (Estimate)
Next Earnings Date
May 16 2025 (Est.)
Latest price
Market Cap | ₹4.38B |
EV | ₹4.47B |
Shares Outstanding | 29.78M |
Beta | 1.47 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 1.00% |
EPS | 0.80% |
Operating Cash Flow | - |
Free Cash Flow | -10.40% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | -28.08% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
Brooks Laboratories Limited
BROOKS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Data Unavailable
Employees
293
Website
www.brookslabs.netIPO Date
2011-09-05
Headquarters
201, The Summit Business Bay, Behind Guru Nanak Petrol Pump, Off. Andheri Kurla Road, Andheri (East), Mumbai, Maharashtra, 400093, India
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved